A collaborative partnership between the Huber Lab, Myeloma UK and the Joyce and Norman Freed Foundation support our research efforts in improving treatment and finding a cure for multiple myeloma. The Freed Foundation recently met with our research team at the Structural Genomics Consortium to hear about the project and its latest progress.
Alison Goldberg said: “Having supported Myeloma UK over many years, my sister Sara and I have been impressed with the impact Myeloma UK and its work has had on myeloma patients. We wanted to visit the SGC and to understand the role they play. We were so impressed with the facilities at the SGC as well as the excellent progress being made with the research. Results from this study will help to optimise the use of current and future treatments. It’s really encouraging to see the impact our funding is having on research.”